Navigation Links
One Million Americans Now Receive Personalized FDA Drug Safety Alerts Through iGuard.org
Date:12/30/2008

tandable, actionable, timely information that they can discuss with their doctors.

Paul Seligman, M.D., M.P.H., Associate Director for Safety Policy and Communication at the FDA, said, "Communicating safety information in a timely fashion is important to all those whoweigh the benefits and risks aboutthe appropriate use of a medicine. Providing this information is a shared responsibility of many in the healthcare system. iGuard.org now provides such a source for this information."

iGuard.org is Different from Other Drug Information Services

Although patients today have access to an enormous set of tools for getting information about their health, iGuard.org is the only service that:

helps patients identify which drugs pose the greatest risk using a personalized, color-coded, drug safety rating system; detects potential interactions between drugs and diseases as well as interactions between drugs – recognizing that drug-disease interactions (e.g., Viagra and heart disease, birth control pills and smoking) are the highest cause of death and disability associated with medication use; communicates emerging product recalls (which outnumber alerts by four to one) as well as safety notifications and FDA advisories; avoids bombarding patients with irrelevant communications by ensuring that drug-specific messages are sent only to those users to whom they apply; ensures that communications are actionable and easy to understand by having a pharmacist review and update FDA / drug company alerts for the consumer audience; allows patients to have their doctor copied on their communications; is funded by medical research, not by advertising, which helps improve medicines. Helping the Scientific Community

iGuard.org connects patients with researchers interested in learning more about how drugs work. iGuard has already helped researchers to document real world rates of side effects for common medications such as
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. AUDIO from Medialink and Pfizer: Number of Uninsured Americans Grows to 47 Million
3. Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New Gold Standard Study by Cincinnati Childrens Researchers
4. 1.5 million children could be saved
5. The Philadelphia Walk Now for Autism Expected to Draw 10,000 Walkers and Raise $1 Million to Help Find Answers About the Nations Fastest-Growing Developmental Disorder
6. UVa researcher awarded $3.6 million grant to fight drug-resistant bacteria
7. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
8. R. P. Simmons Family Foundation Pledges $2 Million for New Childrens Hospital of Pittsburgh of UPMC Campus
9. £5 million investment in personalized medicines to cut patient deaths
10. Keane Wins $1 Million Electronic Medical Record (EMR) Implementation at New Jersey-Based Acute Care Facility
11. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
 One Million Americans Now Receive Personalized FDA Drug Safety Alerts Through iGuard.org 
(Date:3/3/2015)... 2015 Loma Linda University Health announced ... well being, it will be offering new, healthier choices ... , Over the past year, a cross-section of Loma ... dietary criteria, listening to vendors, sampling their products, and ... , Most recently, a food fair was held ...
(Date:3/3/2015)... Man, Woman & Student of the Year ... and ensure access to treatments for blood cancer patients, ... their families. Through this annual national ten-week campaign, individuals ... a world without blood cancers. The national titles will ... to be announced this summer. To date, these dedicated ...
(Date:3/3/2015)... Today the Brain Injury Association of America ... snow, water, and motorcycle helmets, announced a partnership agreement ... kicks off with Nutcase donating $2 from each helmet ... BIAA during the month of March in recognition of ... the nation in observing Brain Injury Awareness Month by ...
(Date:3/3/2015)... Dr. Michael Nochomovitz has ... clinical integration and network development officer for ... established role, Dr. Nochomovitz is responsible for ... physician enterprise, its integration within NewYork-Presbyterian and ... Physicians. , Dr. Nochomovitz brings 17 years ...
(Date:3/3/2015)... 2015 The first week of March ... Foundation. The event brings recognition to a rarely discussed ... According to the Centers for Disease Control , ... form or another. Too little or unrestful sleep is ... illness and depression, and even a higher likelihood of ...
Breaking Medicine News(10 mins):Health News:Loma Linda University Health Rejuvenates Its Vending Machines with Healthier Selections 2Health News:The Leukemia & Lymphoma Society’s Oregon and SW Washington Chapter Kicks Off Their Eleventh Annual Man, Woman & Student of the Year Campaign 2Health News:The Leukemia & Lymphoma Society’s Oregon and SW Washington Chapter Kicks Off Their Eleventh Annual Man, Woman & Student of the Year Campaign 3Health News:Brain Injury Association of America Partners with Nutcase Helmets to Raise Awareness About Brain Injury 2Health News:Dr. Michael Nochomovitz to Lead Clinical Integration and Network Development for the NewYork-Presbyterian Healthcare System 2Health News:Dr. Michael Nochomovitz to Lead Clinical Integration and Network Development for the NewYork-Presbyterian Healthcare System 3Health News:Dr. Michael Nochomovitz to Lead Clinical Integration and Network Development for the NewYork-Presbyterian Healthcare System 4Health News:Medicationdiscountcard.com recognizes sleep awareness week with discounts on sleep meds including Ambien, Lunesta, and Sonata 2Health News:Medicationdiscountcard.com recognizes sleep awareness week with discounts on sleep meds including Ambien, Lunesta, and Sonata 3
... Over ... their subscribers and readers demand for more alkaline and organic food…, , ... (PRWEB) June 14, 2010 -- TheAlkalineDiet.org has just ... products from all over the world. Since the launch of the website in November 2009, ...
... patients who directly confronted the stress of the Second Lebanon ... with the situation by focusing on feelings. This has been ... the University of Haifa, the Technion-Israel Institute of Technology and ... sclerosis to date, it is important to uncover all the ...
... recommended A1c blood test cutoff didn,t accurately diagnose elderly ... -- Despite its endorsement last year by the American ... 2 diabetes, new research out of Singapore suggests that ... the disease among elderly Asians. , The American Diabetes ...
... ... Horizon Healthcare Services, Inc. to Put Evidence-Based Medicine into Practice with Via Oncology Pathways ... Pittsburgh ... will continue to improve as a result of wider application of Via Oncology™ Pathways, ...
... ... ,Camera to data toggle application revolutionizes any Windows Mobile Device with Camera and replaces any ... ... of the Kodak roll film camera in 1888, engineers, inspectors and professionals have used a ...
... ... The Verdin Company announced today it has acquired ... a leader in manufacturing architectural site furnishings. The Verdin Company, ... installer of clocks, bells, carillons, bell and clock towers, glockenspiels, and ...
Cached Medicine News:Health News:Official Alkaline Diet Site Launches Organic Food Store for Healthy Living And Natural Weight Loss 2Health News:Official Alkaline Diet Site Launches Organic Food Store for Healthy Living And Natural Weight Loss 3Health News:Can multiple sclerosis attacks be minimized in a war zone? 2Health News:Age, Race May Affect Type 2 Diabetes Screening Results 2Health News:Hematology-Oncology Associates of Northern New Jersey (HOANNJ) Joins Effort to Improve Cancer Care with Via Oncology™ Pathways 2Health News:Hematology-Oncology Associates of Northern New Jersey (HOANNJ) Joins Effort to Improve Cancer Care with Via Oncology™ Pathways 3Health News:Mobile and Patented: DATA-TO-CAMERA TOGGLE on handheld device replaces old camera and clipboard approach everywhere! Beats IPAD to camera punch too..... 2Health News:The Verdin Company Acquires Canterbury International, an industry leader in architectural site furnishings for over 50 years 2Health News:The Verdin Company Acquires Canterbury International, an industry leader in architectural site furnishings for over 50 years 3
(Date:3/3/2015)... 2015  AT&T 1 and Royal Philips ...  is the connectivity provider for Philips GoSafe, Philips, leading ... provide peace of mind to seniors at home or ... active lives with the confidence that they can get ... network 2 helps power GoSafe and connects seniors ...
(Date:3/3/2015)... 2015   VWR  (NASDAQ:  VWR), a leading, ... announced today the expansion of its distribution agreement ... allows VWR increased access to NEB,s growing product ... and Puerto Rico.  In addition, customers will now ... platform, sales organization, and VWRCATALYST, our onsite services ...
(Date:3/3/2015)... , March 3, 2015  The eleventh annual Tucson ... of the world,s top research scientists, academics, oncologists and ... theories and learn about new outcomes in patient treatments ... Each year Ventana Medical Systems, Inc. ... sponsors the Tucson Symposium at the Hilton El Conquistador ...
Breaking Medicine Technology:AT&T Providing Connectivity for Philips GoSafe Mobile Medical Alert System, Empowering United States Seniors to be Connected to Emergency Care On-the-Go 2AT&T Providing Connectivity for Philips GoSafe Mobile Medical Alert System, Empowering United States Seniors to be Connected to Emergency Care On-the-Go 3AT&T Providing Connectivity for Philips GoSafe Mobile Medical Alert System, Empowering United States Seniors to be Connected to Emergency Care On-the-Go 4VWR Announces Expansion of Distribution Agreement with New England Biolabs 2Global scientific collaborators to explore latest pathology and oncology advancements at Tucson Symposium 2
... Data presented at the 2008 iSBTc Annual Meeting -, ... 11:00 a.m. ET to discuss,results -, BRANFORD, Conn., ... today preliminary data from an ongoing Phase II,trial of ... of patients with unresectable Stage III or Stage IV ...
... at AASLD annual meeting, Pivotal Phase III ... failed prior treatment, SAN FRANCISCO, Nov. 1 ... that a planned interim analysis of a,Phase II ... C,protease inhibitor, in combination with peginterferon and ribavirin,markedly ...
Cached Medicine Technology:CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 2CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 3CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 4CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 5CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 6CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 7Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 2Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 3Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 4Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 5Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 6Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 7Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 8Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 9Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 10
Used for stenting the urethra after hypospadias or epispadias repair and to provide post-operative drainage of the bladder. Supplied sterile in peel-open packages. Intended for one-time use....
... for temporary internal drainage ... to the bladder. Supplied ... Intended for one-time use. ... advised; C-Flex® and Sof-Flex® ...
Used to introduce Cook-Cope loop and other catheters for percutaneous nephrostomy. Supplied sterile in peel-open packages. Intended for one-time use....
Used to establish a percutaneous tract into the renal pelvis for catheter placement or stone manipulation. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: